Tag Archives: MedImmune

MedImmune Bets Its Fate on “Biobetters”

AstraZeneca’s biologics shop makes a decisive move in the biosimilars market. MedImmune, the biologics shop bought by AstraZeneca (AZ) for a staggering $15 billion in 2007 promising one new drug a year for the foundering British firm, has made precious little news since the deal. But all of a sudden the post-Labor Day wires were […]
Posted in Biotech, Deals, Global, R&D, Strategy | Also tagged , , , , , | 1 Comment
  • Categories

  • Meta